Cited by 917Pancreatic function and diabetesDiabetes Treatment and ManagementDiabetes Management and Research

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

Open access

Perley, Michael J., Kipnis, David M.·1967·Journal of Clinical Investigation

Open this paper in CoChat — free account Open PDF

Abstract

The plasma insulin responses of normal weight and obese, diabetic, and nondiabetic subjects to intravenous glucose was only 30-40% of that seen after oral glucose, indicating that alimentary mechanism(s) in addition to the arterial blood sugar concentration regulate insulin secretion. Observations made in subjects with diverted portal circulation indicate that the alimentary insulinogenic mechanism is located in the intestinal tract. The insulinogenic potency of the alimentary and glycemic stimuli expressed in terms of insulin secretion per gram of glucose were remarkably similar within each group of individuals. Between these groups, however, there were considerable differences. Obesity, with or without associated diabetes, was associated with a true hypersecretory responsiveness, whereas diabetes was characterized, with or without obesity, by a marked impairment in insulin secretion. The experimental design used in these studies permitted quantitation of the magnitude of the glycemic component of an oral glucose load. As a consequence of impaired insulin secretion, a greater than normal proportion of the oral glucose load escapes initial hepatic extraction in the maturity-onset diabetic and enters the peripheral circulation. Therefore, in the noninsulin-requiring maturity-onset diabetic, the glycemic insulinogenic stimulus for a given oral glucose load is significantly greater than in normal subjects and accounts for the excessive plasma insulin responses observed late in the course of an oral glucose tolerance test.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci105685

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

DETERMINATION OF BLOOD SUGAR
Somogyi, M. (1945) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43098-0 · Cited by 1,788
Plasma Insulin Response to Oral and Intravenous Glucose Administration1
ELRICK, H., STIMMLER, L., HLAD, C. J., & ARAI, Y. (1964) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-24-10-1076 · Cited by 857
Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*
Seltzer, H. S., Allen, E. W., Herron, A. L., & Brennan, M. T. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105534 · Cited by 819 · cited 1×
“(24) and Cerasi and Luft (25) that insulin secretion is impaired in diabetes mellitus.”
Background
New Interpretation of Oral Glucose Tolerance
Mcintyre, N., Holdsworth, C. D., & Turner, D. S. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90011-x · Cited by 738
Promotion of Insulin Secretion by Glucagon
Samols, E., Marri, G., & Marks, V. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90761-0 · Cited by 521
Intestinal Factors in the Control of Insulin Secretion
McIntyre, N., Holdsworth, C. D., & Turner, D. S. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1317 · Cited by 382
THE PLASMA INSULIN RESPONSE TO GLUCOSE INFUSION IN HEALTHY SUBJECTS AND IN DIABETES MELLITUS
Cerasi, E., & Luft, R. (1967) · Acta Endocrinologica · doi:10.1530/acta.0.0550278 · Cited by 371
Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects
Perley, M., & Kipnis, D. M. (1966) · Diabetes · doi:10.2337/diab.15.12.867 · Cited by 330
Self-citation
Plasma Insulin Concentrations in Nondiabetic and Early Diabetic Subjects: Determinations by a New Sensitive Immuno-assay Technic
Yalow, R. S., & Berson, S. A. (1960) · Diabetes · doi:10.2337/diab.9.4.254 · Cited by 330
PLASMA INSULIN AND GROWTH HORMONE LEVELS IN OBESITY AND DIABETES
Yalow, R. S., Glick, S. M., Roth, J., & Berson, S. A. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb34803.x · Cited by 199

Flagged first, then by citations

Show all 24 references

Sorted by citations

Items 601–700 of 914

Food proteins in the regulation of blood glucose control
Luhovyy, B. L., & Kathirvel, P. (2022) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2022.05.001 · Cited by 9
Agonistas del receptor de péptido similar al glucagón tipo 1 (GLP-1) en el manejo del paciente con diabetes mellitus tipo 2. Una aproximación para el nefrólogo
Cases, A. (2022) · Nefrología · doi:10.1016/j.nefro.2022.07.008 · Cited by 11
New drugs for the treatment of type 2 diabetes
Chowdhury, T. A., & Hossain, B. (2007) · British Journal of Hospital Medicine · doi:10.12968/hmed.2007.68.4.178 · Cited by 8
Insulin Secretion in Type II Diabetes Mellitus
Kudva, Y. C., & Butler, P. C. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-3906-0_7 · Cited by 8
Preservation of the incretin effect after orthotopic pancreas transplantation in inbred rats
Kissler, H. J., Gepp, H., Schmiedl, A., & Schwille, P. O. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90065-3 · Cited by 8
β‐Cell Dysfunction in Type 2 Diabetes
Utzschneider, K. M., & Kahn, S. E. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0403 · Cited by 8
Clinical studies with gastric inhibitory polypeptide
Brown, J. C., & Otte, S. C. (1979) · World Journal of Surgery · doi:10.1007/bf01654758 · Cited by 8
Increased glucose disposal after jejuno-ileostomy
Rehfeld, J. F., Lauritsen, K. B., & Holst, J. J. (1979) · Diabetologia · doi:10.1007/bf00423147 · Cited by 8
Interrelationship of Nutrition and Endocrinology
Eisenstein, A. B. (1968) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/21.5.467 · Cited by 8
The Entero-insular Axis and the Metabolic Effects of Gastro-enteropancreatic Polypeptides
DUPRÉ, J. (1980) · Clinics in Gastroenterology · doi:10.1016/s0300-5089(21)00480-6 · Cited by 8
Nutrient synchrony in preruminant calves
van den Borne, J. J. G. C. (2006) · doi:10.18174/19267 · Cited by 8
Antiobesity medications in adult and pediatric obesity and metabolic dysfunction–associated steatotic liver disease
Rodriguez, N. S., & Hartmann, P. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100058 · Cited by 10
Small-Molecule GLP-1 Receptor Agonists: A Promising Pharmacological Approach
Șeremet, O. C., Pușcașu, C., Andrei, C., Nițulescu, G., Zbârcea, C. E., & Olaru, O. T. (2025) · Medicina · doi:10.3390/medicina61111902 · Cited by 7
IUPHAR review: From foe to friend: Repurposing glucagon to treat obesity and type 2 diabetes
Elmendorf, A. J., Yousefian, M., Kim, I., Hardaway, J. A., Habegger, K. M., & Flak, J. N. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108077 · Cited by 7
Carbohydrate Ingestion on Exercise Metabolism and Physical Performance
Noakes, T. D., Prins, P., Buga, A., D'Agostino, D. P., Volek, J. S., & Koutnik, A. P. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf038 · Cited by 11
New Incretin Hormonal Therapies in Humans Relevant to Diabetic Cats
Reusch, C. E., & Padrutt, I. (2013) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2012.11.003 · Cited by 8
Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies
Shaefer, C. F. (2016) · Clinical Diabetes · doi:10.2337/diaclin.34.2.81 · Cited by 7
Adipose Lipolysis Unchanged by Preexercise Carbohydrate Regardless of Glycemic Index
Baur, D., Willingham, B. D., Smith, K. A., Kisiolek, J. N., Morrissey, M. C., Saracino, P. G., Ragland, T. J., & Ormsbee, M. J. (2017) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001498 · Cited by 7
A low GLP-1 response among patients treated for acute organophosphate and carbamate poisoning: a comparative cross-sectional study from an agrarian region of Sri Lanka
Rathish, D., Senavirathna, I., Jayasumana, C., Agampodi, S. B., & Siribaddana, S. (2018) · Environmental Science and Pollution Research · doi:10.1007/s11356-018-3818-9 · Cited by 7
The insulinotropic and incretin response to feeding a milk based protein matrix in healthy young women
Amigo‐Benavent, M., Power-Grant, O., Fitzgerald, R. J., & Jakeman, P. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104056 · Cited by 7
Designer GLP1 poly-agonist peptides in the management of diabesity
Statham, L., Pelling, M., Hanson, P., Kyrou, I., Randeva, H. S., & Barber, T. M. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2204976 · Cited by 7
Pharmacology of GLP-1 agonists: describing the therapeutic potential to patients.
Spellman, C. (2011) · PubMed · Cited by 7
Insulin Sensitivity as a Risk Factor for Common Carotid Intima Media Thickness (IMT): Its Relation to Atherosclerosis
Deo, S. S., Mahadik, S. R., Chogle, A. R., Soneji, S. L., & Lulla, C. P. (2007) · Clinical and Experimental Hypertension · doi:10.1080/10641960701615667 · Cited by 7
Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM
Ratheiser, K., Reitgruber, W., Komjati, M., Bratusch-Marrain, P. R., Vierhapper, H., & Waldhäusl, W. K. (1990) · Acta Diabetologica · doi:10.1007/bf02581332 · Cited by 7
Surgical Approaches for the Prevention and Treatment of Type 2 Diabetes Mellitus
Coffin, S. T., Konduru, C., Schwarcz, M., & Frishman, W. H. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e3181bc23d1 · Cited by 7
Technosphere Inhaled Insulin: Is Faster Better?
Leahy, J. L. (2015) · Diabetes Care · doi:10.2337/dci15-0002 · Cited by 7
Withdrawal of medications leads to worsening of OGTT parameters in youth with impaired glucose tolerance or recently‐diagnosed type 2 diabetes
Hannon, T. S., Edelstein, S. L., Arslanian, S. A., Caprio, S., Zeitler, P. S., Buchanan, T. A., Ehrmann, D. A., Mather, K. J., Tripputi, M., Kahn, S. E., et al. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13129 · Cited by 7
Metabolic Syndrome and Type 2 Diabetes: Can We Stop the Weight Gain with Diabetes?
Joffe, D. C., & Yanagisawa, R. T. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.06.002 · Cited by 7
Carbohydrate Metabolism and Acute Myocardial Infarction: Circulating Glucose, Insulin, Cortisol and Growth Hormone Responses and Excretion of Catecholamines
Kurt, T. L., Genton, E., Chidsey, C. A., Beck, P. A., & Sussman, K. E. (1973) · CHEST Journal · doi:10.1378/chest.64.1.21 · Cited by 7
Diabetes: Lessons of Epidemiology
Jarrett, R. J. (1970) · BMJ · doi:10.1136/bmj.3.5717.270 · Cited by 7
Regulation of Insulin Secretion in Vivo
Vidal, J., & Kahn, S. E. (2001) · Endocrine updates · doi:10.1007/978-1-4615-1597-5_7 · Cited by 7
Clinical aspects of GIP secretion
Beck, B., Villaume, C., & Debry, G. (1982) · Acta Diabetologica · doi:10.1007/bf02581180 · Cited by 7
Alimentary hypoglycemia: a new appraisal
Leichter, S. B. (1979) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/32.10.2104 · Cited by 7
Insulin and Glucagon Secretion in vivo and its Neural Control
Taborsky, G. J. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070206 · Cited by 7
Increased binding of insulin to mononuclear blood cells following gastric bypass for morbid obesity
Kramer, J. L., Halverson, J. D., Thomas, L. L., & Santiago, J. V. (1982) · Journal of Surgical Research · doi:10.1016/0022-4804(82)90111-1 · Cited by 7
Is Exenatide A Useful Addition to Diabetes Therapy?
Mikhail, N. E. (2006) · Endocrine Practice · doi:10.4158/ep.12.3.307 · Cited by 7
Does Diabetes Begin with Insulin Resistance?
KIPNIS, D. M. (1970) · Elsevier eBooks · doi:10.1016/b978-0-12-027361-4.50025-9 · Cited by 7
Self-citation
Assessment of the incretin effect in healthy subjects: concordance between clamp and OGTT methods
Aulinger, B. A., & D’Alessio, D. A. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00104.2022 · Cited by 6
Remission and relapse of diabetes after sleeve gastrectomy and one‐anastomosis gastric bypass: The Tehran Obesity Treatment Study
Sadeghi, S., Hosseinpanah, F., Khalaj, A., Ebadinejad, A., Mahdavi, M., Valizadeh, M., & Barzin, M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15974 · Cited by 11
The neuro-incretin concept
Åhrén, B. (2014) · Regulatory Peptides · doi:10.1016/j.regpep.2014.09.003 · Cited by 6
Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes
Gredal, C., Rosenfalck, A. M., Dejgaard, A., & Hilsted, J. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.12.023 · Cited by 6
Glucose tolerance, insulin secretion, and glucose utilization in subjects after gastric surgery
Leichter, S. B., Arnold, A., & Lewis, S. (1977) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/30.12.2053 · Cited by 6
Insulin is secreted upon glucose stimulation by both gastrointestinal enteroendocrine K-cells and L-cells engineered with the preproinsulin gene
Encina, G., Ezquer, F. E., Conget, P. A., & Israel, Y. (2011) · Biological Research · doi:10.4067/s0716-97602011000300012 · Cited by 6
Effects of various routes of caffeine administration on oral and intravenous glucose tolerance tests in dogs
DeCastro, O. A. P., Sandberg, H., Feinberg, L. J., & Bellet, S. (1969) · Metabolism · doi:10.1016/0026-0495(69)90111-5 · Cited by 6
Secretion and Hepatic Extraction of Insulin in Nondiabetic, Obese, Aged Subjects
Bonora, E., Coscelli, C., & BUTTURINI, U. (1983) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1983.tb05742.x · Cited by 6
The Intestinal Insulinotropic Action after Jejuno-Ileostomy
Rehfeld, J. F., Juhl, E., & QUAADE, F. (1970) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.1970.12096560 · Cited by 6
Discrepant Performance on Oral and Intravenous Glucose Tolerance Tests: The Role ofGastric Inhibitory Polypeptide
Elahi, D., Andersen, D. K., Tobin, J. D., & Andres, R. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-52-6-1199 · Cited by 6
Recent Developments in Body Fuel Metabolism
Felig, P. (1976) · Springer eBooks · doi:10.1007/978-1-4684-7656-9_4 · Cited by 6
Status of pancreatic transplants and mechanical devices for blood glucose control in diabetes
Santiago, J. V., & White, N. H. (1980) · Annals of Biomedical Engineering · doi:10.1007/bf02363451 · Cited by 6
The Incretin Concept
Creutzfeldt, W., & Ebert, R. (1988) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027311-9.50014-7 · Cited by 6
A simple method for regulating and monitoring circulating glucose levels.
Costrini, N. V., Ganeshappa, K. P., Whalen, G. E., & Soergel, K. H. (1973) · PubMed · Cited by 6
Introduction
Tobin, B. W., & Miller, G. D. (2001) · Journal of Nutrition · doi:10.1093/jn/131.2.333s · Cited by 6
Über die Bedeutung der Duodenalpassage fur die Insulin-und Gastrinsekretion des Patienten nach totaler Magenentfemung
Bittner, R., Beger, H. G., Willert, B., & Marzinzig, E. (1979) · Langenbecks Archiv für Chirurgie. Supplement · doi:10.1007/978-3-642-67291-0_23 · Cited by 6
Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit
Thomas, J., Dagan, M., Wang, B. H., Gutman, S., & Kaye, D. M. (2026) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.013279 · Cited by 8
Type 2 diabetes risk alleles in peptidyl-glycine alpha-amidating monooxygenase influence GLP-1 levels and response to GLP-1 receptor agonists
Umapathysivam, M. M., Araldi, E., Hastoy, B., Dawed, A. Y., Vatandaslar, H., Mayrhofer, J. E., Lindquist, P., Silva, P. N., Goga, A., Trüllinger, G. O., et al. (2026) · Genome Medicine · doi:10.1186/s13073-026-01630-0 · Cited by 14
1. What is Type 2 Diabetes Mellitus? Crucial Role of Maladaptive Changes in Beta Cell and Adipocyte Biology
Leahy, J. L., & Pratley, R. E. (2011) · Translational endocrinology & metabolism · doi:10.1210/team.9781879225824.ch1 · Cited by 5
Infrared Spectroscopy for Rapid Triage of Cancer Using Blood Derivatives: A Reality Check
Nazeer, S. S., Venkataraman, R. K., Jayasree, R. S., & Bayry, J. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c02590 · Cited by 5
Exenatide once-weekly injection for the treatment of type 2 diabetes in Chinese patients: current perspectives
Deng, W., Qiu, S., Yang, G., & Chen, B. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s81088 · Cited by 5
Blunted Insulinemia Using High Dialysate Glucose Concentration During Hemodialysis
Czabak-Garbacz, R., Schneditz, D., Zierler, E., Eichmann, E., Harter, G., Hafner-Gießauf, H., & Obermayer-Pietsch, B. M. (2011) · ASAIO Journal · doi:10.1097/mat.0b013e318229aaa4 · Cited by 5
The relationship between insulin resistance and insulin secretion in japanese subjects with borderline glucose intolerance
Wasada, T., ARII, H., Kuroki, H., Saeki, A., Katsumori, K., Saito, S., & Omori, Y. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01149-8 · Cited by 5
Targeting the Incretin System in Type 2 Diabetes Mellitus
Potenza, M. V., & Rayfield, E. J. (2009) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20112 · Cited by 5
A Study of Serum Uric Acid Levels in Type 2 Diabetes Mellitus Subjects: A Cross Sectional Study
Shirsath, A. D., Patil, V. C., Mane, M. B., & Patil, S. (2019) · International Journal of Contemporary Medical Research [IJCMR] · doi:10.21276/ijcmr.2019.6.1.22 · Cited by 5
Incretins: the novel therapy of type 2 diabetes.
Thongtang, N., & Sriwijitkamol, A. (2008) · PubMed · Cited by 5
Use of Exenatide in Patients With Type 2 Diabetes
Hood, R. C., Valentine, V., Mac, S. M., & Polonsky, W. H. (2006) · Diabetes Spectrum · doi:10.2337/diaspect.19.3.181 · Cited by 6
Secretion uncouples glucose inhibition of glucagon-producing cells resulting in a simultaneous stimulation of both glucagon and insulin release
Kofod, H., Holst, J. J., & Lernmark, Å. (1988) · Regulatory Peptides · doi:10.1016/0167-0115(88)90232-7 · Cited by 5
Beyond Glycemic Control
Martin, C. L. (2008) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721708319238 · Cited by 5
The Role of the Liver in Insulin Action and Resistance
Radziuk, J., & Pye, S. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-716-1_11 · Cited by 5
The Incretin Modulators – Incretin Mimetics (GLP-1 Receptor Agonists) and Incretin Enhancers (DPP-4 Inhibitors)
Nauck, M. A., Schmidt, W. E., & Meier, J. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6_12 · Cited by 5
In vitro stimulation of glucose utilization by insulin in primary cultures of rat hepatocytes
Suzuki, M., Kojima, H., Nakano, T., Kashiwagi, A., Hidaka, H., Kosugi, K., Shigeta, Y., & Harano, Y. (1991) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(91)90060-q · Cited by 5
Hyperinsulinemia and hypertensionDo intestinal hormones play a role?
Tedde, R., Pala, A., Melis, A., Sechi, G., Bilotta, F., & REALDI, G. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(94)00182-b · Cited by 5
The response of serum glucose, free fatty acid and immunoreactive insulin to oral glucose and intravenous tolbutamide in normal, potentially diabetic and diabetic subjects
Bigelow-Sherman, J. D., Shima, K., Borden, E. K., Penhallegon, R., & Foà, P. P. (1970) · Acta Diabetologica · doi:10.1007/bf01556774 · Cited by 5
BETA BLOCKERS, BLOOD SUGARS, AND THIAZIDES
Gove, I., Kendall, M. J., & O’Rahilly, S. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92111-7 · Cited by 5
Physiology and Pathophysiology of GLP-1
Göke, B., Göke, R., Fehmann, H. C., & Bode, H. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61150-6_17 · Cited by 6
Reduction of C-peptide secretion in noninsulin-dependent diabetic patients with long duration of insulin treatment.
Hsieh, S. D., Akanuma, Y., Kawazu, S., Mashiko, S., Kanazawa, Y., Iwamoto, Y., Kikuchi, M., & Kosáka, K. (1983) · Endocrinologia Japonica · doi:10.1507/endocrj1954.30.373 · Cited by 5
Gastroentero-Pancreatic Hormones in Pregnancy
HORNNES, P. J. (1984) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.1984.12005751 · Cited by 5
GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight
Patel, T., Rose, J., Katsurada, K., Yada, T., Koutakis, P., Salomon, J., Patel, K. P., & Alfaidi, M. (2026) · Circulation Research · doi:10.1161/circresaha.126.327683 · Cited by 4
Pancreatic β cell function versus insulin resistance: application of the hyperbolic law of glucose tolerance
Bergman, R. N. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176738 · Cited by 4
A collectanea of food insulinaemic index: 2023
Hendricks, S. A., Paul, M. J., Subramaniam, Y., & Vijayam, B. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.06.017 · Cited by 6
Control metabólico y pérdida de peso en pacientes con obesidad y diabetes mellitus tipo 2 tratados con exenatida
Pujante, P., Gil, M. D. H., Román, L. M., Gómez, M. F., Zafra, M. V. G., & Massó, J. T. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2011.10.025 · Cited by 4
Incretins and Regulation of Insulin Secretion
Nauck, M. A., & Meier, J. J. (2008) · Springer eBooks · doi:10.1007/978-4-431-75452-7_17 · Cited by 4
Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study
Myat, A., Arri, S. S., Bhatt, D. L., Gersh, B. J., Redwood, S. R., & Marber, M. S. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0193-4 · Cited by 4
Systems Pharmacology Modeling in Type 2 Diabetes Mellitus
Bosley, J., Maurer, T. S., & Musante, C. J. (2016) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-44534-2_20 · Cited by 4
Alimentary hypoglycemia associated with the Zollinger-Ellison syndrome
O'Brien, T. K., Tijtgat, G. N. J., & Ensinck, J. W. (1973) · The American Journal of Medicine · doi:10.1016/0002-9343(73)90122-8 · Cited by 4
Insulin increases excitability via a dose‐dependent dual inhibition of voltage‐activated K+ currents in differentiated N1E‐115 neuroblastoma cells
Lima, P. A., Vicente, M. I., Alves, F. M., Dionı́sio, J. C., & Costa, P. F. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06150.x · Cited by 4
I.V. Glucose tolerance test: Correlation between FFA, glucose and IRI in normal, obese and diabetic subjects
Prando, R., Cordera, R., Micheli, A. D., Maiello, M., Odetti, P. R., Viviani, G. L., Corsi, L., & Adezati, L. (1978) · Acta Diabetologica · doi:10.1007/bf02590749 · Cited by 4
Plasma amino acid values and pancreatic β‐cell function in phenylketonuria
Antonozzi, I., Carducci, C., Vestri, L., Manzari, V., & Dominici, R. (1986) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799491 · Cited by 4
Normal β‐cell function
Natali, A., Prato, S. D., & Mari, A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch8 · Cited by 4
Changes in plasma insulin related to the type of dietary carbohydrate in overweight hyperlipidemic male patients.
Rodger, N. W., Squires, B., & Du, E. L. (1971) · PubMed Central · Cited by 4
Glucagon and Glucagon‐like Peptide Production and Degradation
Kieffer, T. J., Hussain, M. A., & Habener, J. F. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070208 · Cited by 4
Insulin resistance and hyperinsulinemia: implications for the pathogenesis and treatment of hypertension.
Buchanan, T. A. (1991) · PubMed · Cited by 4
A la recherche du temps perdu — epilogue to the Minkowski award lecture 1974
Cerasi, E. (1985) · Diabetologia · doi:10.1007/bf00281988 · Cited by 4
Cholecystokinin and gastric inhibitory polypeptide not glucagonotropic in dogs
Sirinek, K. R., Levine, B. A., Crockett, S. E., & Cataland, S. (1980) · Journal of Surgical Research · doi:10.1016/0022-4804(80)90097-9 · Cited by 4
Extrapancreatic and pancreatic actions of glibenclamide in rats
Heptner, W., Zermatten, A., Kellner, H., Christ, O., & Felber, J. P. (1977) · Diabetologia · doi:10.1007/bf01223276 · Cited by 4
Regulation of glucagon-like peptide-I receptor expression and transcription by the protein kinase C pathway
Fehmann, H.-C., Schweinfurth, J., Jiang, J., & Göke, B. (1996) · Research in Experimental Medicine · doi:10.1007/bf02576844 · Cited by 4
The incretin mimetic, exenatide: a novel treatment option for type 2 diabetes
Schnabel, C. A. (2005) · The British Journal of Diabetes · doi:10.1177/14746514050050040801 · Cited by 4
Suppression of Insulin Secretion by Falling Plasma Glucose Levels is Impaired in Type 2 Diabetes
Hosker, J. P., Burnett, M. A., Matthews, D. R., & Turner, R. C. (1988) · Diabetic Medicine · doi:10.1111/j.1464-5491.1988.tb01124.x · Cited by 4
STANDARDIZATION AND EVALUATION OF THE ORAL GLUCOSE TOLERANCE TEST
Carter, N. G., & Maynard, J. H. (1970) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1970.tb84590.x · Cited by 4
Dynamic recruitment of Munc13 primes docked secretory granules for exocytosis
Echeverry, S., Saras, J., Lund, P.-E., Dunevall, J., Gandasi, N. R., & Barg, S. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116301 · Cited by 3
Efficacy and Safety of Mitiglinide in Korean Type 2 Diabetic Patients: Prospective Randomised Multicenter Comparative Phase III Study
Kim, S. Y., Kim, H.-J., Han, K. A., Baek, S. H., Son, H. S., Soo, B., & Min, K. W. (2007) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2007.31.2.163 · Cited by 3
WITHDRAWN: Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes
Lovshin, J. A. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.02.003 · Cited by 3
Retracted

Authors: Perley, M. J., & Kipnis, D. M.
Affiliations: Washington University in St. Louis (US)
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1967-12-01
Volume: 46
Issue: 12
Pages: 1954-1962
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci105685
PMC: PMC292948
OpenAlex: W2169558934
Cited by: 917
References: 24
Citations by year: 2026: 12 · 2025: 12 · 2024: 15 · 2023: 17 · 2022: 12 · 2021: 16 · 2020: 20 · 2019: 25 · 2018: 15 · 2017: 15 · 2016: 28 · 2015: 33 · 2014: 13 · 2013: 25 · 2012: 16
FWCI: 60.63
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords: insulin secretion, oral glucose tolerance, intravenous glucose, obesity, type 2 diabetes, hypersecretion, insulin resistance
MeSH terms: Adolescent, Adult, Aged, Arteries, Capillaries, Child, Diabetes Mellitus, Glucose, Humans, Infusions, Parenteral, Insulin, Middle Aged, Obesity, Veins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks